Anggot, Elnie I.
HRN: 23-23-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2023
CEFUROXIME 1.5GM (VIAL)
07/18/2023
07/18/2023
IVT
1.5g
Q8 X 3 More Doses
S/P LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes